Dietary oils and FADS1-FADS2 genetic variants modulate [13C]α-linolenic acid metabolism and plasma fatty acid composition

Am J Clin Nutr. 2013 Jan;97(1):195-207. doi: 10.3945/ajcn.112.043117. Epub 2012 Dec 5.

Abstract

Background: Desaturation of dietary α-linolenic acid (ALA) to omega-3 (n-3) long-chain fatty acids (FAs) is mediated through FA desaturases (FADS1-FADS2) and may be influenced by dietary FA composition.

Objective: We investigated the effects of diets enriched in flaxseed oil (FXCO) or high-oleic acid canola oil (HOCO) compared with a Western diet (WD) and FADS1-FADS2 single nucleotide polymorphisms (SNPs) on plasma FAs and [U-(13)C]ALA metabolism.

Design: In a randomized crossover design, 36 hyperlipidemic subjects consumed 3 isoenergetic diets enriched in FXCO (20.6 g ALA/d), HOCO (2.4 g ALA/d), or WD (1.3 g ALA/d) for 4 wk. On day 27, blood was sampled 0, 24, and 48 h after the subjects (n = 26) consumed 45 mg [U-(13)C]ALA. The subjects were genotyped for 4 FADS SNPs.

Results: FXCO increased (P < 0.001) plasma ALA, EPA, and docosapentaenoic acid (DPA), with no change in DHA compared with the HOCO or WD diets. At 24 and 48 h, [U-(13)C]ALA recovered as plasma [(13)C]EPA and [(13)C]DPA were lower (P < 0.001) after the FXCO diet than after the HOCO and WD diets. No change in [(13)C]DHA was observed between diets. Minor allele homozygotes of rs174545, rs174583, rs174561, and rs174537 had lower (P < 0.05) plasma EPA, arachidonic acid (AA), EPA/ALA, and AA/linoleic acid compositions and lower (P < 0.05) plasma [(13)C]EPA enrichment at 24 and 48 h in comparison with carriers of the major allele after all diets. SNPs were not associated with plasma composition of DHA or [(13)C]DHA enrichment.

Conclusion: An increase in ALA intake resulting in increased plasma EPA composition may be cardioprotective, especially in minor allele homozygotes. This trial was registered at www.clinicaltrials.gov as NCT00927199.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Alleles
  • Arachidonic Acid / administration & dosage
  • Arachidonic Acid / blood
  • Biomarkers / blood
  • Cross-Over Studies
  • Delta-5 Fatty Acid Desaturase
  • Diet
  • Dietary Fats, Unsaturated / administration & dosage
  • Dietary Fats, Unsaturated / blood
  • Docosahexaenoic Acids / administration & dosage
  • Docosahexaenoic Acids / blood
  • Eicosapentaenoic Acid / administration & dosage
  • Eicosapentaenoic Acid / blood
  • Fatty Acid Desaturases / genetics*
  • Fatty Acids / blood*
  • Fatty Acids, Monounsaturated / administration & dosage
  • Fatty Acids, Monounsaturated / blood
  • Female
  • Humans
  • Linoleic Acid / administration & dosage
  • Linoleic Acid / blood
  • Linseed Oil / administration & dosage
  • Lipid Metabolism
  • Lipids / blood
  • Male
  • Middle Aged
  • Oleic Acid / administration & dosage
  • Oleic Acid / blood
  • Polymorphism, Single Nucleotide
  • Rapeseed Oil
  • Single-Blind Method
  • Young Adult
  • alpha-Linolenic Acid / administration & dosage*
  • alpha-Linolenic Acid / blood*

Substances

  • Biomarkers
  • Delta-5 Fatty Acid Desaturase
  • Dietary Fats, Unsaturated
  • Fatty Acids
  • Fatty Acids, Monounsaturated
  • Lipids
  • Rapeseed Oil
  • alpha-Linolenic Acid
  • Docosahexaenoic Acids
  • Arachidonic Acid
  • Oleic Acid
  • Linseed Oil
  • Linoleic Acid
  • Eicosapentaenoic Acid
  • Fatty Acid Desaturases
  • FADS1 protein, human
  • FADS2 protein, human

Associated data

  • ClinicalTrials.gov/NCT00927199